ATECVSRARE• 6 Months (Normalized)
ATEC vs RARE (Alphatec Holdings Inc. vs Ultragenyx Pharmaceutical Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ATEC Performance $10.66
-13.82%
Alphatec Holdings Inc.
Normalized Baseline0.00%
RARE Performance $12.95
-34.85%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
Alpha Spread Margin ATEC LEADS
+21.03%
ATEC outperforming by 21.03%
ATECRARE
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ATEC RARE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ATEC Price | ATEC Gain (%) | RARE Price | RARE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $10.66 | -13.82% | $12.95 | -34.85% | +21.03% |
| Sep 15, 2026 | $10.66 | -13.82% | $13.07 | -34.22% | +20.40% |
| Sep 14, 2026 | $10.86 | -12.21% | $13.61 | -31.50% | +19.29% |
| Sep 11, 2026 | $10.58 | -14.47% | $14.30 | -28.03% | +13.56% |
| Sep 10, 2026 | $8.84 | -28.54% | $14.40 | -27.53% | -1.01% |
| Sep 09, 2026 | $8.99 | -27.32% | $14.31 | -27.98% | +0.66% |
| Sep 08, 2026 | $9.19 | -25.71% | $14.88 | -25.11% | -0.60% |
| Sep 04, 2026 | $9.45 | -23.61% | $15.30 | -23.00% | -0.61% |
| Sep 03, 2026 | $9.33 | -24.58% | $14.85 | -25.26% | +0.68% |
| Sep 02, 2026 | $9.19 | -25.71% | $26.53 | +33.52% | -59.23% |
| Sep 01, 2026 | $9.21 | -25.55% | $25.81 | +29.89% | -55.44% |
| Aug 31, 2026 | $9.37 | -24.25% | $25.21 | +26.87% | -51.12% |
| Aug 28, 2026 | $9.44 | -23.69% | $25.61 | +28.89% | -52.58% |
| Aug 27, 2026 | $9.57 | -22.64% | $26.26 | +32.16% | -54.80% |
| Aug 26, 2026 | $9.42 | -23.85% | $26.44 | +33.06% | -56.91% |
Page 1 of 9